379 related articles for article (PubMed ID: 15044750)
21. Positron emission tomography imaging in evaluation of cancer patients.
Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
[TBL] [Abstract][Full Text] [Related]
22. Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
Hillner BE; Tosteson AN; Song Y; Tosteson TD; Onega T; Goodman DC; Siegel BA
J Am Coll Radiol; 2012 Jan; 9(1):33-41. PubMed ID: 22221634
[TBL] [Abstract][Full Text] [Related]
23. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
24. PET in lung cancer staging.
Coleman RE
Q J Nucl Med; 2001 Sep; 45(3):231-4. PubMed ID: 11788815
[TBL] [Abstract][Full Text] [Related]
25. [Positron emission tomography in oncology].
Hatazawa J; Higuchi I; Nakamura H
Gan To Kagaku Ryoho; 2003 Jun; 30(6):748-54. PubMed ID: 12852339
[TBL] [Abstract][Full Text] [Related]
26. Clinical oncologic positron emission tomography: an introduction.
Turkington TG; Coleman RE
Semin Roentgenol; 2002 Apr; 37(2):102-9. PubMed ID: 12134363
[TBL] [Abstract][Full Text] [Related]
27. FDG PET: advantages for staging the mediastinum?
Franzius C
Lung Cancer; 2004 Aug; 45 Suppl 2():S69-74. PubMed ID: 15552784
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
Kostakoglu L; Goldsmith SJ
J Nucl Med; 2003 Feb; 44(2):224-39. PubMed ID: 12571214
[TBL] [Abstract][Full Text] [Related]
29. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
30. [Role of 18F-FDG positron emission tomography in surgical evaluation].
Franzius C; Sciuk J; Schober O
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():261-9. PubMed ID: 9931622
[TBL] [Abstract][Full Text] [Related]
31. PET imaging in oncology.
Bar-Shalom R; Valdivia AY; Blaufox MD
Semin Nucl Med; 2000 Jul; 30(3):150-85. PubMed ID: 10928381
[TBL] [Abstract][Full Text] [Related]
32. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
Laking G; Price P
Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
[No Abstract] [Full Text] [Related]
33. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
[TBL] [Abstract][Full Text] [Related]
34. A surgical perspective on positron emission tomography.
Gulec SA
J Surg Oncol; 2007 May; 95(6):443-6. PubMed ID: 17221861
[No Abstract] [Full Text] [Related]
35. Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT.
Karantanis D; Subramaniam RM; Mullan BP; Peller PJ; Wiseman GA
J Comput Assist Tomogr; 2007; 31(5):800-5. PubMed ID: 17895795
[TBL] [Abstract][Full Text] [Related]
36. [Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Esophageal cancer].
Noboru O
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):265-9. PubMed ID: 12073632
[TBL] [Abstract][Full Text] [Related]
37. 18-Fluorodeoxyglucose imaging in oncology.
Harolds JA
J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
[TBL] [Abstract][Full Text] [Related]
38. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
[TBL] [Abstract][Full Text] [Related]
39. Value of FDG PET in the management of NSCLC.
Ukena D; Hellwig D
Lung Cancer; 2004 Aug; 45 Suppl 2():S75-8. PubMed ID: 15552785
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
